Find the right
DNA test

The most recognized name in consumer DNA testing. Offers health predisposition reports including BRCA1/BRCA2, carrier status screening, and ancestry composition across 2,000+ geographic regions. FDA-authorized health reports.

The largest consumer DNA database with over 25 million users. Specializes in ethnicity estimates and family tree building with access to billions of historical records. Traits add-on for wellness and appearance insights.

Strong alternative to AncestryDNA with a large European user base. Provides ethnicity estimates across 42 ethnicities and worldwide DNA matches. Integrated family tree builder and photo enhancement tools.

One of the oldest genetic genealogy companies, founded in 2000. Uniquely offers Y-DNA and mtDNA tests for deep paternal and maternal lineage tracing. Surname and geographical DNA projects unmatched in the industry.

UK-based company with exceptionally detailed regional breakdowns, especially within the British Isles (21 sub-regions). Combines ancestry with wellbeing reports. Data kept in EU under GDPR.

Offers 30x whole genome sequencing, capturing nearly 100% of your DNA versus the 0.02% that genotyping chips cover. Regularly updated reports as new research emerges. Blockchain-based consent management emphasizes data ownership.

European-based 30x WGS provider. Delivers comprehensive health report, pharmacogenomic analysis, and ancestry composition. Rare disease screening panels and nutrition-focused reports from full genetic data.

Marketplace platform for sequencing and DNA analysis apps. 30x WGS available alongside raw data uploads from all major services. Purchase individual health, ancestry, or wellness reports through their marketplace.

Spanish genotyping-based health and ancestry reports covering 400+ conditions. Drug response, inherited conditions, and personal traits. Multi-language platform with a user-friendly results dashboard.

Hong Kong-based whole exome sequencing covering all protein-coding regions. 500+ reports spanning health risks, cancer screening, pharmacogenetics, ancestry, and wellness. Premium kit includes diet and fitness recommendations.

Combines ancestry and health reporting with user-friendly timelines. Proprietary algorithm delivers ancestry reports going back 50+ generations and health reports covering conditions, traits, and nutrition.

Health and wellness focused. Accepts raw DNA data uploads from 23andMe, AncestryDNA, and others then generates personalized supplement, diet, and exercise recommendations. Action-oriented reports for daily health decisions.

Now part of Labcorp. Comprehensive genetic testing across cardiology, neurology, oncology, pediatrics, and reproductive health. Physician-ordered with genetic counseling. Tested over 4 million patients.

Cell-free DNA testing for oncology, women's health, and organ health. Signatera test is a pioneering personalized ctDNA assay for cancer monitoring. Panorama is one of the most widely used NIPT tests in the US.

Pioneer in liquid biopsy technology. Guardant360 analyzes ctDNA from a blood draw to identify genomic alterations across 74 genes. FDA-approved companion diagnostic helping oncologists select targeted therapies.

Known for Cologuard, the at-home colon cancer screening test. Oncotype DX analyzes gene activity in breast, colon, and prostate tumors to predict recurrence risk and chemotherapy benefit.

Pioneer in hereditary cancer testing with 25+ years of experience. myRisk panel assesses 48 genes for hereditary cancers. BRACAnalysis was the first commercial test for BRCA1/2 mutations.

Clinical lab specializing in hereditary disease testing. Panels for cancer, cardiovascular, neurological, and rare diseases. Known for rigorous variant interpretation and comprehensive gene coverage.

Leading provider of exome and genome sequencing for rare disease diagnosis. Analyzed over 500,000 clinical exomes. Focuses on pediatric and adult rare disease with WES and WGS ordered by specialists.

Population health genomics platform. Offers hereditary cancer and heart health genetic testing through employers and health systems. Includes genetic counseling and clinical-grade reports.

Professional pharmacogenetic testing service providing medication guidance across mental health, pain management, and cardiovascular drugs. Physician-ordered with clinical decision support tools.

AI-driven precision medicine platform combining genomic sequencing with clinical data analysis. Tempus offers comprehensive genomic profiling for oncology, cardiology, and psychiatry alongside pharmacogenomic guidance integrated with real-world evidence.

Mayo Clinic-backed pharmacogenomic testing platform. Analyzes how genetic variations affect response to 300+ medications. Provides a personalized medication report for patients and clinicians.

Myriad Genetics' pharmacogenomic test focused on mental health medications. Analyzes genetic variations affecting response to antidepressants, antipsychotics, and mood stabilizers. Widely used in psychiatric practice.

Leading NIPT using SNP-based technology. Screens for common chromosomal abnormalities including trisomies 21, 18, 13, and sex chromosome aneuploidies. Also offers 22q11.2 deletion syndrome screening.

Labcorp's NIPT screening for fetal chromosomal abnormalities. Analyzes cell-free fetal DNA from maternal blood. Screens for trisomies 21, 18, 13, and sex chromosome conditions with high sensitivity and specificity.

Carrier screening and NIPT using molecular counting technology. Screens for cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies alongside fetal aneuploidy screening. High accuracy at low fetal fractions.